The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn

References

• Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med 2012; 4:165rv13; PMID:23253612
   PubMed Web of Science ®Google Scholar
• Martins N, Ferreira IC, Barros L, Silva S, Henriques M. Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia 2014; 177:223-40; PMID:24789109; http://dx.doi.org/10.1007/s11046-014-9749-1
   PubMed Web of Science ®Google Scholar
• Parker JE, Warrilow AG, Price CL, Mullins JG, Kelly DE, Kelly SL. Resistance to antifungals that target CYP51. J Chem Biol 2014; 7:143-61; PMID:25320648; http://dx.doi.org/10.1007/s12154-014-0121-1
   PubMedGoogle Scholar
• Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 2010; 9:719-27; PMID:20725094; http://dx.doi.org/10.1038/nrd3074
   PubMed Web of Science ®Google Scholar
• Solomon SL, Oliver KB. Antibiotic resistance threats in the United States: stepping back from the brink. Am Fam Physician 2014; 89:938-41; PMID:25162160
   PubMed Web of Science ®Google Scholar
• Xie JL, Polvi EJ, Shekhar-Guturja T, Cowen LE. Elucidating drug resistance in human fungal pathogens. Future Microbiol 2014; 9:523-42; PMID:24810351; http://dx.doi.org/10.2217/fmb.14.18
   PubMed Web of Science ®Google Scholar
• Noel T. The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs. J Mycol Med 2012; 22:173-8; PMID:23518020; http://dx.doi.org/10.1016/j.mycmed.2012.04.004
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Sagar N, Hirschi KD. Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae. Antimicrob Agents Chemother 1999; 43:2798-800; PMID:10543768
   PubMed Web of Science ®Google Scholar
• Coste A, Selmecki A, Forche A, Diogo D, Bougnoux ME, d'Enfert C, Berman J, Sanglard D. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell 2007; 6:1889-904; PMID:17693596; http://dx.doi.org/10.1128/EC.00151-07
   PubMed Web of Science ®Google Scholar
• Schubert S, Rogers PD, Morschhauser J. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Antimicrob Agents Chemother 2008; 52:4274-80; PMID:18809934; http://dx.doi.org/10.1128/AAC.00740-08
   PubMed Web of Science ®Google Scholar
• Prasad R, Kapoor K. Multidrug resistance in yeast Candida. Int Rev of Cytol 2005; 242:215-48; PMID:15598470; http://dx.doi.org/10.1016/S0074-7696(04)42005-1
   PubMedGoogle Scholar
• Liu TT, Znaidi S, Barker KS, Xu L, Homayouni R, Saidane S, Morschhäuser J, Nantel A, Raymond M, Rogers PD. Genome-wide expression and location analyses of the Candida albicans Tac1p regulon. Eukaryot Cell 2007; 6:2122-38; PMID:17905926; http://dx.doi.org/10.1128/EC.00327-07
   PubMed Web of Science ®Google Scholar
• Dunkel N, Blass J, Rogers PD, Morschhauser J. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol 2008; 69:827-40; PMID:18577180; http://dx.doi.org/10.1111/j.1365-2958.2008.06309.x
   PubMed Web of Science ®Google Scholar
• Karababa M, Valentino E, Pardini G, Coste AT, Bille J, Sanglard D. CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol 2006; 59:1429-51; PMID:16468987; http://dx.doi.org/10.1111/j.1365-2958.2005.05037.x
   PubMed Web of Science ®Google Scholar
• Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infec Dis 2010; 202:171-5; PMID:20497051; http://dx.doi.org/10.1086/651200
   PubMed Web of Science ®Google Scholar
• Daum G, Wagner A, Czabany T, Athenstaedt K. Dynamics of neutral lipid storage and mobilization in yeast. Biochimie 2007; 89:243-8; PMID:16919863; http://dx.doi.org/10.1016/j.biochi.2006.06.018
   PubMed Web of Science ®Google Scholar
• Abe F, Usui K, Hiraki T. Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae. Biochemistry 2009; 48:8494-504; PMID:19670905; http://dx.doi.org/10.1021/bi900578y
   PubMed Web of Science ®Google Scholar
• Sgherri C, Porta A, Castellano S, Pinzino C, Quartacci MF, Calucci L. Effects of azole treatments on the physical properties of Candida albicans plasma membrane: a spin probe EPR study. Biochimica Et Biophysica Acta 2014; 1838:465-73; PMID:24184423; http://dx.doi.org/10.1016/j.bbamem.2013.10.015
   PubMed Web of Science ®Google Scholar
• Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annu Rev of Genet 2007; 41:401-27; PMID:17666007; http://dx.doi.org/10.1146/annurev.genet.41.110306.130315
   PubMed Web of Science ®Google Scholar
• Bard M, Sturm AM, Pierson CA, Brown S, Rogers KM, Nabinger S, Eckstein J, Barbuch R, Lees ND, Howell SA, et al. Sterol uptake in Candida glabrata: rescue of sterol auxotrophic strains. Diagn Microbiol Infect Dis 2005; 52:285-93; PMID:15893902; http://dx.doi.org/10.1016/j.diagmicrobio.2005.03.001
   PubMed Web of Science ®Google Scholar
• Zavrel M, Hoot SJ, White TC. Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae. Eukaryot Cell 2013; 12:725-38; PMID:23475705; http://dx.doi.org/10.1128/EC.00345-12
   PubMed Web of Science ®Google Scholar
• Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Rolley N, Kelly DE, Kelly SL. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrob Agents Chemother 2010; 54:4527-33; PMID:20733039; http://dx.doi.org/10.1128/AAC.00348-10
   PubMed Web of Science ®Google Scholar
• Theesfeld CL, Hampton RY. Insulin-induced gene protein (INSIG)-dependent sterol regulation of Hmg2 endoplasmic reticulum-associated degradation (ERAD) in yeast. J Biol Chem 2013; 288:8519-30; PMID:23306196; http://dx.doi.org/10.1074/jbc.M112.404517
   PubMed Web of Science ®Google Scholar
• Pasrija R, Krishnamurthy S, Prasad T, Ernst JF, Prasad R. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. J Antimicrob Chemother 2005; 55:905-13; PMID:15845783; http://dx.doi.org/10.1093/jac/dki112
   PubMed Web of Science ®Google Scholar
• Kennedy MA, Johnson TA, Lees ND, Barbuch R, Eckstein JA, Bard M. Cloning and sequencing of the Candida albicans C-4 sterol methyl oxidase gene (ERG25) and expression of an ERG25 conditional lethal mutation in Saccharomyces cerevisiae. Lipids 2000; 35:257-62; PMID:10783002; http://dx.doi.org/10.1007/s11745-000-0521-2
   PubMed Web of Science ®Google Scholar
• Aaron KE, Pierson CA, Lees ND, Bard M. The Candida albicans ERG26 gene encoding the C-3 sterol dehydrogenase (C-4 decarboxylase) is essential for growth. FEMS Yeast Res 2001; 1:93-101; PMID:12702354; http://dx.doi.org/10.1111/j.1567-1364.2001.tb00020.x
   PubMed Web of Science ®Google Scholar
• Pierson CA, Jia N, Mo C, Lees ND, Sturm AM, Eckstein J, Barbuct R, Bard M. Isolation, characterization, and regulation of theCandidaalbicansERG27gene encoding the sterol 3-keto reductase. Med Mycol 2004; 42:461-73; PMID:15552648; http://dx.doi.org/10.1080/1369378032000141471
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay K, Prasad T, Saini P, Pucadyil TJ, Chattopadhyay A, Prasad R. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob Agents Chemother 2004; 48:1778-87; PMID:15105135; http://dx.doi.org/10.1128/AAC.48.5.1778-1787.2004
   PubMed Web of Science ®Google Scholar
• Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL. A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. Antimicrob Agents Chemother 2010; 54:3578-83; PMID:20547793; http://dx.doi.org/10.1128/AAC.00303-10
   PubMed Web of Science ®Google Scholar
• Jensen-Pergakes KL, Kennedy MA, Lees ND, Barbuch R, Koegel C, Bard M. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants. Antimicrob Agents Chemother 1998; 42:1160-7; PMID:9593144
   PubMed Web of Science ®Google Scholar
• Jia N, Arthington-Skaggs B, Lee W, Pierson CA, Lees ND, Eckstein J, Barbuch R, Bard M. Candida albicans Sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site. Antimicrob Agents Chemother 2002; 46:947-57; PMID:11897574; http://dx.doi.org/10.1128/AAC.46.4.947-957.2002
   PubMed Web of Science ®Google Scholar
• Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL. A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. Antimicrob Agents Chemother 2010; 54:3578-83; PMID:20547793; http://dx.doi.org/10.1128/AAC.00303-10
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 2003; 47:2404-12; PMID:12878497; http://dx.doi.org/10.1128/AAC.47.8.2404-2412.2003
   PubMed Web of Science ®Google Scholar
• Keller P, Muller C, Engelhardt I, Hiller E, Lemuth K, Eickhoff H, Wiesmüller KH, Burger-Kentischer A, Bracher F, Rupp S. An antifungal benzimidazole derivative inhibits ergosterol biosynthesis and reveals novel sterols. Antimicrob Agents Chemother 2015; 59:6296-307; PMID:26248360; http://dx.doi.org/10.1128/AAC.00640-15
   PubMed Web of Science ®Google Scholar
• Pierson CA, Eckstein J, Barbuch R, Bard M. Ergosterol gene expression in wild-type and ergosterol-deficient mutants of Candida albicans. Med Mycol 2004; 42:385-9; PMID:15473366; http://dx.doi.org/10.1080/13693780410001712016
   PubMed Web of Science ®Google Scholar
• Liu TT, Lee RE, Barker KS, Lee RE, Wei L, Homayouni R, Rogers PD. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 2005; 49:2226-36; PMID:15917516; http://dx.doi.org/10.1128/AAC.49.6.2226-2236.2005
   PubMed Web of Science ®Google Scholar
• Arthington-Skaggs BA1, Jradi H, Desai T, Morrison CJ. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 1999; 10:3332-7; PMID:10488201
   PubMed Web of Science ®Google Scholar
• Morio F, Pagniez F, Lacroix C, Miegeville M, Le Pape P. Amino acid substitutions in the Candida albicans sterol Delta5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J Antimicrob Chemother 2012; 67:2131-8; PMID:22678731; http://dx.doi.org/10.1093/jac/dks186
   PubMed Web of Science ®Google Scholar
• Bard M, Lees ND, Barbuch RJ, Sanglard D. Characterization of a cytochrome P450 deficient mutant of Candida albicans. Biochem Biophys Res Commun 1987; 147:794-800; PMID:3307785; http://dx.doi.org/10.1016/0006-291X(87)91000-X
   PubMed Web of Science ®Google Scholar
• Shapiro RS, Robbins N, Cowen LE. Regulatory circuitry governing fungal development, drug resistance, and disease. MMBR 2011; 75:213-67; PMID:21646428; http://dx.doi.org/10.1128/MMBR.00045-10
   PubMed Web of Science ®Google Scholar
• Cruz MC, Goldstein AL, Blankenship JR, Del Poeta M, Davis D, Cardenas ME, Perfect JR, McCusker JH, Heitman J. Heitman J. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 2002; 21:546-59; PMID:11847103; http://dx.doi.org/10.1093/emboj/21.4.546
   PubMed Web of Science ®Google Scholar
• Golabek K, Strzelczyk JK, Owczarek A, Cuber P, Slemp-Migiel A, Wiczkowski A. Selected mechanisms of molecular resistance of Candida albicans to azole drugs. Acta Biochimica Polonica 2015; 62:247-51; PMID:25901298; http://dx.doi.org/10.18388/abp.2014_940
   PubMed Web of Science ®Google Scholar
• Liu JY, Shi C, Wang Y, Li WJ, Zhao Y, Xiang MJ. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China. Res in Microbiol 2015; 166:153-61; PMID:25748216; http://dx.doi.org/10.1016/j.resmic.2015.02.009
   PubMed Web of Science ®Google Scholar
• Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N, Ellis D, Xiao M, Widmer F, Chen SC. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. BMC Microbiology 2009; 9:167; PMID:19682357; http://dx.doi.org/10.1186/1471-2180-9-167
   PubMed Web of Science ®Google Scholar
• Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrob Agents Chemother 2013; 57:3182-93; PMID:23629718; http://dx.doi.org/10.1128/AAC.00555-13
   PubMed Web of Science ®Google Scholar
• Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE, Morschhäuser J, Rogers PD. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot Cell 2012; 11:1289-99; PMID:22923048; http://dx.doi.org/10.1128/EC.00215-12
   PubMed Web of Science ®Google Scholar
• Kim KY, Shin YK, Park JC, Kim JH, Yang H, Han DM, Paik YK. Molecular cloning and biochemical characterization of Candida albicans acyl-CoA:sterol acyltransferase, a potential target of antifungal agents. Biochem Biophys Res Commun 2004; 319:911-9; PMID:15184069; http://dx.doi.org/10.1016/j.bbrc.2004.05.076
   PubMed Web of Science ®Google Scholar
• Beller M, Thiel K, Thul PJ, Jackle H. Lipid droplets: a dynamic organelle moves into focus. FEBS Lett 2010; 584:2176-82; PMID:20303960; http://dx.doi.org/10.1016/j.febslet.2010.03.022
   PubMed Web of Science ®Google Scholar
• Ishida K, Fernandes Rodrigues JC, Cammerer S, Urbina JA, Gilbert I, de Souza W, Rozental S. Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis. Ann Clin Microbiol Antimicrob 2011; 10:3; PMID:21255433; http://dx.doi.org/10.1186/1476-0711-10-3
   PubMed Web of Science ®Google Scholar
• Debelyy MO, Thoms S, Connerth M, Daum G, Erdmann R. Involvement of the Saccharomyces cerevisiae hydrolase Ldh1p in lipid homeostasis. Eukaryot Cell 2011; 10:776-81; PMID:21478434; http://dx.doi.org/10.1128/EC.05040-11
   PubMed Web of Science ®Google Scholar
• Klug L, Daum G. Yeast lipid metabolism at a glance. FEMS Yeast Res 2014; 14:369-88; PMID:24520995; http://dx.doi.org/10.1111/1567-1364.12141
   PubMed Web of Science ®Google Scholar
• Culakova H, Dzugasova V, Valencikova R, Gbelska Y, Subik J. Stress response and expression of fluconazole resistance associated genes in the pathogenic yeast Candida glabrata deleted in the CgPDR16 gene. Microbiol Res 2015; 174:17-23; PMID:25946325; http://dx.doi.org/10.1016/j.micres.2015.03.004
   PubMed Web of Science ®Google Scholar
• Bien CM, Espenshade PJ. Sterol regulatory element binding proteins in fungi: hypoxic transcription factors linked to pathogenesis. Eukaryot Cell 2010; 9:352-9; PMID:20118213; http://dx.doi.org/10.1128/EC.00358-09
   PubMed Web of Science ®Google Scholar
• Maguire SL, Wang C, Holland LM, Brunel F, Neuveglise C, Nicaud JM, Zavrel M, White TC, Wolfe KH, Butler G. Zinc finger transcription factors displaced SREBP proteins as the major Sterol regulators during Saccharomycotina evolution. PLoS Genet 2014; 10:e1004076; PMID:24453983; http://dx.doi.org/10.1371/journal.pgen.1004076
   PubMedGoogle Scholar
• Silver PM, Oliver BG, White TC. Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell 2004; 3:1391-7; PMID:15590814; http://dx.doi.org/10.1128/EC.3.6.1391-1397.2004
   PubMed Web of Science ®Google Scholar
• MacPherson S, Akache B, Weber S, De Deken X, Raymond M, Turcotte B. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob Agents Chemother 2005; 49:1745-52; PMID:15855491; http://dx.doi.org/10.1128/AAC.49.5.1745-1752.2005
   PubMed Web of Science ®Google Scholar
• Hoot SJ1, Brown RP, Oliver BG, White TC. The UPC2 promoter in Candida albicans contains two cis-acting elements that bind directly to Upc2p, resulting in transcriptional autoregulation. Eukaryot Cell 2010; 9:1354-1362; PMID:20656915; http://dx.doi.org/10.1128/EC.00130-10
   PubMed Web of Science ®Google Scholar
• Gallo-Ebert C, Donigan M, Stroke IL, Swanson RN, Manners MT, Francisco J, Toner G, Gallagher D, Huang CY, Gygax SE, et al. Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factor. Antimicrob Agents Chemother 2014; 58:258-66; PMID:24145546; http://dx.doi.org/10.1128/AAC.01677-13
   PubMed Web of Science ®Google Scholar
• Sellam A, Tebbji F, Nantel A. Role of Ndt80p in sterol metabolism regulation and azole resistance in Candida albicans. Eukaryot Cell 2009; 8:1174-83; PMID:19542309; http://dx.doi.org/10.1128/EC.00074-09
   PubMed Web of Science ®Google Scholar
• Sasse C, Schillig R, Dierolf F, Weyler M, Schneider S, Mogavero S, Rogers PD, Morschhäuser J. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans. PLoS One 2011; 6:1-9; PMID:21980509; http://dx.doi.org/10.1371/journal.pone.0025623
   PubMed Web of Science ®Google Scholar
• Prasad T, Hameed S, Manoharlal R, Biswas S, Mukhopadhyay CK, Goswami SK, Prasad R. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res 2010; 10:587-96; PMID:20491944
   PubMed Web of Science ®Google Scholar
• Schneiter R, Brugger B, Sandhoff R, Zellnig G, Leber A, Lampl M, Athenstaedt K, Hrastnik C, Eder S, Daum G, et al. Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane. J Cell Biol 1999; 146:741-54; PMID:10459010; http://dx.doi.org/10.1083/jcb.146.4.741
   PubMed Web of Science ®Google Scholar
• Kartsonis NA, Nielsen J, Douglas CM. Caspofungin: the first in a new class of antifungal agents. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 2003; 6:197–218.
   Google Scholar
• Martin SW, Konopka JB. Lipid raft polarization contributes to hyphal growth in Candida albicans. Eukaryot Cell 2004; 3:675-84; PMID:15189988; http://dx.doi.org/10.1128/EC.3.3.675-684.2004
   PubMed Web of Science ®Google Scholar
• Mollinedo F. Lipid raft involvement in yeast cell growth and death. Front in Oncol 2012; 2:140; PMID:23087902; http://dx.doi.org/10.3389/fonc.2012.00140
   PubMedGoogle Scholar
• Insenser M, Nombela C, Molero G, Gil C. Proteomic analysis of detergent-resistant membranes from Candida albicans. Proteomics 2006; 6(Suppl 1):S74-81; PMID:16534748; http://dx.doi.org/10.1002/pmic.200500465
   PubMedGoogle Scholar
• Pasrija R1, Panwar SL, Prasad R. Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob Agents Chemother 2008; 52:694-704; PMID:18056285; http://dx.doi.org/10.1128/AAC.00861-07
   PubMed Web of Science ®Google Scholar
• Thorpe GW, Fong CS, Alic N, Higgins VJ, Dawes IW. Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes. Proc Natl Acad Sci USA 2004; 101:6564-9; PMID:15087496; http://dx.doi.org/10.1073/pnas.0305888101
   PubMed Web of Science ®Google Scholar
• Umebayashi K, Nakano A. Ergosterol is required for targeting of tryptophan permease to the yeast plasma membrane. J Cell Biol 2003; 161:1117-31; PMID:12810702; http://dx.doi.org/10.1083/jcb.200303088
   PubMed Web of Science ®Google Scholar
• O'Meara TR, Veri AO, Ketela T, Jiang B, Roemer T, Cowen LE. Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat Commun 2015; 6:6741; PMID:25824284; http://dx.doi.org/10.1038/ncomms7741
   PubMed Web of Science ®Google Scholar
• Odds FC, Cockayne A, Hayward J, Abbott AB. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. J Gen Microbiol 1985; 131:2581-9; PMID:2999296
   PubMedGoogle Scholar
• Hornby JM, Kebaara BW, Nickerson KW. Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B. Antimicrob Agents Chemother 2003; 47:2366-9; PMID:12821501; http://dx.doi.org/10.1128/AAC.47.7.2366-2369.2003
   PubMed Web of Science ®Google Scholar
• Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006; 9:588-94; PMID:17055772; http://dx.doi.org/10.1016/j.mib.2006.10.003
   PubMed Web of Science ®Google Scholar
• Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183:5385-94; PMID:11514524; http://dx.doi.org/10.1128/JB.183.18.5385-5394.2001
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 2003; 71:4333-40; PMID:12874310; http://dx.doi.org/10.1128/IAI.71.8.4333-4340.2003
   PubMed Web of Science ®Google Scholar
• Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 2004; 3:536-45; PMID:15075282; http://dx.doi.org/10.1128/EC.3.2.536-545.2004
   PubMed Web of Science ®Google Scholar
• Olsen I. Attenuation of Candida albicans virulence with focus on disruption of its vacuole functions. J Oral Microbiol 2014; 6:23898; PMID:24765242
   PubMed Web of Science ®Google Scholar
• Luna-Tapia A, Peters BM, Eberle KE, Kerns ME, Foster TP, Marrero L, Noverr MC, Fidel PL Jr, Palmer GE. ERG2 and ERG24 are required for normal vacuolar physiology as well as Candida albicans pathogenicity in a murine model of disseminated but not vaginal candidiasis. Eukaryot Cell 2015; 14(10):1006-16; PMID:26231054
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Gamarra S, Garcia-Effron G, Park S, Perlin DS, Rao R. Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs. PLoS Pathog 2010; 6:e1000939; PMID:20532216; http://dx.doi.org/10.1371/journal.ppat.1000939
   PubMed Web of Science ®Google Scholar
• Sun N, Fonzi W, Chen H, She X, Zhang L, Zhang L, Calderone R. Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants. Antimicrob Agents Chemother 2013; 57:532-42; PMID:23147730; http://dx.doi.org/10.1128/AAC.01520-12
   PubMed Web of Science ®Google Scholar
• Thomas E, Roman E, Claypool S, Manzoor N, Pla J, Panwar SL. Mitochondria influence CDR1 efflux pump activity, Hog1-mediated oxidative stress pathway, iron homeostasis, and ergosterol levels in Candida albicans. Antimicrob Agents Chemother 2013; 57:5580-99; PMID:23979757; http://dx.doi.org/10.1128/AAC.00889-13
   PubMed Web of Science ®Google Scholar
• Chen C, Pande K, French SD, Tuch BB, Noble SM. An iron homeostasis regulatory circuit with reciprocal roles in Candida albicans commensalism and pathogenesis. Cell Host Microbe 2011; 10:118-35; PMID:21843869; http://dx.doi.org/10.1016/j.chom.2011.07.005
   PubMed Web of Science ®Google Scholar
• Prasad T, Chandra A, Mukhopadhyay CK, Prasad R. Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells. Antimicrob Agents Ch 2006; 50:3597-606; PMID:16954314; http://dx.doi.org/10.1128/AAC.00653-06
   PubMed Web of Science ®Google Scholar
• Hameed S, Dhamgaye S, Singh A, Goswami SK, Prasad R. Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans. PloS one 2011; 6:e18684; PMID:21533276; http://dx.doi.org/10.1371/journal.pone.0018684
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Rao R. Beyond ergosterol: linking pH to antifungal mechanisms. Virulence 2010; 1:551-4; PMID:21178501; http://dx.doi.org/10.4161/viru.1.6.13802
   PubMed Web of Science ®Google Scholar
• Heese-Peck A. Multiple functions of sterols in yeast endocytosis. Mole Biolo Cell 2002; 13:2664-80; PMID:12181337; http://dx.doi.org/10.1091/mbc.E02-04-0186
   PubMed Web of Science ®Google Scholar
• Crowley JH, Tove S, Parks LW. A calcium-dependent ergosterol mutant of Saccharomyces cerevisiae. Curr Genet 1998; 34:93-9; PMID:9724410; http://dx.doi.org/10.1007/s002940050371
   PubMed Web of Science ®Google Scholar
• Welihinda AA, Beavis AD, Trumbly RJ. Mutations in LIS1 (ERG6) gene confer increased sodium and lithium uptake in Saccharomyces cerevisiae. Biochimica Et Biophysica Acta 1994; 1193:107-17; PMID:8038180; http://dx.doi.org/10.1016/0005-2736(94)90339-5
   PubMed Web of Science ®Google Scholar
• Anderson TM, Clay MC, Cioffi AG, Diaz KA, Hisao GS, Tuttle MD, Nieuwkoop AJ, Comellas G, Maryum N, Wang S, et al. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol 2014; 10:400-6; PMID:24681535; http://dx.doi.org/10.1038/nchembio.1496
   PubMed Web of Science ®Google Scholar